Document:

Stock Purchase Agreement

			
	Attorney-Client Privileged and Confidential 	 	EXHIBIT 10.49

 Xerium
Technologies, Inc. 
 Stock Purchase Agreement 
 The undersigned (the “Purchaser”) hereby subscribes to purchase 795,280 unregistered shares of common stock, par value
$0.01 per share (the “Unregistered Shares”), in a private placement from Xerium Technologies, Inc., a Delaware corporation (the “Corporation”). As consideration for the Unregistered Shares, the Purchaser shall pay
to the Corporation $0.6775per share for an aggregate price of $825,000(the “Purchase Price”). Such price per share represents the average closing price on the New York Stock Exchange of the Corporation’s shares of common stock
on the 20 trading days prior to January 1, 2010. The offer and sale of the Unregistered Shares are being made in reliance upon the provisions of Section 4(2) under the Securities Act of 1933, as amended (the “Securities
Act”). The Purchaser shall pay the Purchase Price on January 2, 2010 by [check] or by such other method as may be acceptable to the Corporation. 
 The Purchaser hereby represents and warrants that: 
 (1) Purchaser is purchasing
the Unregistered Shares for Purchaser’s own account for investment only, and not with the view to the resale or distribution thereof. 
 (2) Purchaser understands that the Unregistered Shares will be subject to the transfer restrictions in the stock certificate legend set forth on Exhibit A hereto. 
 (3) Purchaser has had the opportunity to review publicly available materials filed by the Corporation with the Securities and Exchange
Commission (“SEC”) pursuant to the Securities Exchange Act of 1934, as amended, including, but not limited to, the Risk Factors related to the Corporation’s business and an investment in its common stock. Purchaser has had an
opportunity to review and have Purchaser’s questions answered by the appropriate officers of the Corporation with respect to the Corporation, desires no further or additional information concerning the Corporation or its operation and deems
such information received and reviewed adequate to evaluate the merits and risks of Purchaser’s investment in the Corporation. Purchaser has sufficient experience in business, financial and investment matters to be able to evaluate the risks
involved in the purchase of the Unregistered Shares and to make an informed investment decision with respect to such purchase. Purchaser can afford a complete loss of the value of the Unregistered Shares and is able to bear the economic risk of
holding the Unregistered Shares for an indefinite period. 
 (4) Purchaser understands that the Unregistered Shares have not
been registered under the Securities Act or under any applicable state securities law and that the Unregistered Shares cannot be sold, transferred, or otherwise disposed of unless subsequently registered under the Securities Act and any applicable
state securities law or an exemption from such registration is then available. Purchaser acknowledges that the Corporation has made no undertaking either to register the Unregistered Shares or to make available any exemption from such registration
or to supply any information to facilitate the sale of the Unregistered Shares. Purchaser further understands and agrees that the Corporation will not honor any attempt by Purchaser to sell, pledge, transfer or otherwise dispose of the Unregistered
Shares in the absence of an effective registration statement under the Securities Act and any applicable state securities laws or an opinion of counsel satisfactory in form and substance to the Corporation that an exemption is available therefrom.
Neither the SEC nor any state securities commission has approved the Unregistered Shares or passed upon or endorsed the merits of this offering. 
 (5) Purchaser understands that the Unregistered Shares may only be offered or sold to an “accredited investor,” as defined in Rule 501 of Regulation D promulgated pursuant to the Securities Act,
and the Purchaser represents that he so qualifies as an “accredited investor.” 

 SIGNATURE 
 Purchaser understands that the Corporation is relying upon the representations and warranties contained herein to ensure its compliance with
the Securities Act and applicable state securities laws, and the rules and regulations promulgated thereunder. 
 This the 1 day
of January, 2010. 
  

	
	PURCHASER:
	
	Stephen R. Light
	
	 /s/ Stephen R. Light

 ACCEPTANCE 
 The foregoing
subscription by Stephen R. Light for the Unregistered Shares is hereby accepted by the Corporation as of the [    ] day of January, 2010. 
  

			
	Xerium Technologies, Inc.
		
	By:	 	 /s/ John G. Raos

	Name:	 	John G. Raos
	Title:	 	Chairman, Compensation Committee

 EXHIBIT A 
 Each certificate representing the Shares which may be issued by the Corporation shall bear the following legend: 
 THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), AND MAY NOT BE
SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THE SECURITIES UNDER THE ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE CORPORATION AND ITS COUNSEL THAT SUCH REGISTRATION IS NOT REQUIRED.Service Agreement of Ian Barlow

 Exhibit 4(c) (iv) 
 3 March 2010 
 Mr Ian Barlow 
 7 St. Luke’s Street 
 London 
 SW3 3RS 
 Dear Ian 
 SMITH & NEPHEW plc (THE “COMPANY”) 
 AND YOUR APPOINTMENT AS A
NON-EXECUTIVE DIRECTOR 
 Following the recommendation of the Nominations Committee, the Board of the Company (the “Board”) is
pleased to confirm your appointment as a non-executive director on the Board of Smith & Nephew plc. This letter sets out the main terms of your appointment to this office. It is agreed that on acceptance of this offer this letter will be a
contract for services and not a contract of employment. You should be aware that your appointment will have to be ratified by the Company’s shareholders at the Annual General Meeting in May 2010 and is subject to the Company’s Articles of
Association as amended from time to time. If there is a conflict between the terms of this letter and the Articles of Association then the articles shall prevail. 
 DUTIES 
  

	1.	The Board as a whole is collectively responsible for promoting the success of the Company by directing and supervising the Company’s affairs. The Board’s role
is to: 

  

	 	a)	provide entrepreneurial leadership to the Company within a framework of prudent and effective controls which enable risk to be assessed and managed;

  

	 	b)	set the Company’s strategic aims, ensure that the necessary financial and human resources are in place for the Company to meet its objectives, and review
management performance; and 

  

	 	c)	set the Company’s values and standards and ensure that its obligations to its shareholders and others are understood and met. 

  

	2.	In your role as a non-executive director you will be required (with the other non-executives) to: 

  

	 	a)	constructively challenge and contribute to the development of strategy; 

  

	 	b)	scrutinise the performance of management in meeting agreed goals and objectives and monitor the reporting of performance; 

  

	 	c)	satisfy yourself that financial information is accurate and that financial controls and systems of risk management are robust and defensible; and

  

	 	d)	have a prime role in appointing, and where necessary removing, senior management and in succession planning and where required by the relevant policy of the Company
from time to time be responsible for determining appropriate levels of remuneration of executive directors. 

  

	3.	You will be required to: 

  

	 	a)	exercise relevant powers under the Company’s Memorandum and Articles of Association; 

  

	 	b)	perform your duties faithfully, efficiently and diligently and use all reasonable endeavours to promote the interests and reputation of the Company;

  

	 	c)	serve on various committees of the Board and attend wherever possible all meetings of such committees. You will be provided with the terms of reference of a committee
on your appointment to such a committee; 

	 	d)	attend wherever possible all Annual General Meetings and Extraordinary General Meetings of the Company; 

  

	 	e)	attend wherever possible all meetings of the Board, which meets at least six times a year, normally at 15 Adam Street, London WC2N 6LA (one meeting a year is held at
one of the major business units); 

  

	 	f)	attend wherever possible the Annual Strategy Review, which is usually held off-site over two days in September; 

  

	 	g)	consider all relevant papers in advance of each meeting in order to ensure that you can play a full part in the work of the Board and its committees;

  

	 	h)	bring independent judgement to bear on issues of strategy, policy, resources, performance and standards of conduct; 

  

	 	i)	make yourself available (on reasonable notice) to provide ad hoc advice to individual directors of the Company. Currently, we do not envisage that this would take more
than three days of your time a year; 

  

	 	j)	provide guidance and direction in planning, developing and enhancing the future strategic direction of the Company; 

  

	 	k)	share responsibility with the other directors for the effective control of the Company and with the other non-executive directors for the supervision of the executive
directors; and 

  

	 	l)	comply with the Financial Services Authority’s Model Code for securities transactions by directors of UK listed companies and with any code of conduct relating to
securities transactions by directors and specified employees issued by the Company from time to time The Smith & Nephew Code of Dealing in Securities will be sent to you on your appointment. 

  

	4.	Overall the Company anticipates that you will need to spend a minimum of 15 days per year fulfilling your duties. This will include the Board Meetings, Annual General
Meetings, one Board away-day each year and Board committee meetings. Site visits by directors are encouraged. In addition, you will be expected to spend an appropriate period of time preparing for each meeting and be prepared to be available for
additional meetings and business when required. By accepting this appointment you confirm that you are able to commit sufficient time to the role to meet the Company’s expectations. 

  

	5.	The Company seeks to adhere to the principles in the Cadbury Report on Corporate Governance, the Greenbury Report on Directors’ Remuneration, the Hampel Report on
Corporate Governance, the Turnbull Report on Internal Control and the Higgs Report on non-executive directors. You will be expected to carry out your duties in accordance with the principles set out in these reports, copies of which are available
from the Company Secretary. 

  

	6.	The performance of the Board and its committees, and of individual directors, is evaluated annually. 

  

	7.	You shall, in pursuance of your duties hereunder, be entitled to request such information from the Company, its subsidiary undertakings (as defined in section 1162 of
the Companies Act 2006 as amended from time to time) or its or their employees, consultants or professional advisers as may be reasonably necessary to enable you to perform your role effectively. The Company shall use its reasonable endeavours to
provide such information promptly. 

 CONFIDENTIALITY 
 During the course of your duties you will have access to confidential information belonging to the Company and its subsidiary undertakings (including, but not limited to, details of suppliers, customers,
margins, know-how, marketing and other relevant business information). Unauthorised disclosure of this information could seriously damage the Company. You will therefore undertake not to use or disclose such information save in pursuance of your
duties or in accordance with any statutory obligation or court or similar order. 
 Your attention is drawn to the rules relating to the
disclosure of price sensitive information. You must not make any statement or do anything which may be a breach of these rules without prior clearance from the Chairman or Company Secretary. 
  

 2 

 OUTSIDE INTERESTS 
 The agreement of the Chairman will have to be sought before you accept any new outside interests which might affect the time you are able to devote to this appointment. 
 In accordance with the principles set out in the Combined Code you will have to inform the Company Secretary of any interests which you have, or acquire,
which might reasonably be thought to jeopardise your independence from the Company. 
 During your appointment you will not be able to take up
any office or employment with, or have any interest in, any firm or company which is or may be in direct or indirect competition with the Company. 
 The Board will determine you to be independent, according to the provisions of the Combined Code. 
 INSURANCE 
 During your appointment you will be covered by the Company’s directors’ and officers’ liability insurance on the terms in place from time to
time. Details of the policy are available from the Company Secretary. The Company does not guarantee to maintain this insurance cover after the termination of your appointment, but you will continue to be covered by the policy or any replacement on
the same basis as the rest of the Board. A deed of indemnity will be put in place between you and the Company. 
 APPOINTMENT 

Your appointment will be from 5 March 2010 and will be terminable at the will of the parties. However, it is envisaged that it will be for an initial
period of 36 months from the date of appointment. The continuation of your appointment depends upon satisfactory performance and re-election at forthcoming Annual General Meetings. 
 All appointments and reappointments to the Board will be subject to the Company’s Articles of Association. If you are not re-elected to your position as a director of the Company by the shareholders
at any time and for any reason then this appointment shall terminate automatically and with immediate effect. 
 On termination of the
appointment you shall only be entitled to such fees as may have accrued to the date of termination together with reimbursement in the normal way of any expenses properly incurred prior to that date. 
 REMUNERATION 
 The fees are £54,000
(subject to income tax and statutory deductions) per annum and will be reviewed each year, the next review being in May 2010. There is an additional allowance relating to inter-continental travel of £3,000 per trip and there will be an
additional fee when you take over as Chairman of the Audit Committee on 6 May 2010. 
 EXPENSES 
 The Company will reimburse you for any expenses that you may incur properly and reasonably in performing your duties and which are properly documented. Such
expenses would include reasonable legal fees if circumstances should arise in which it was necessary for you to seek separate legal advice about the performance of your duties. In such a situation, you will be required to discuss the issue either
with me or with one of your non-executive colleagues in advance. 
 INDEPENDENT PROFESSIONAL ADVICE 
 In some circumstances you may think that you will need professional advice in the furtherance of your duties as a director. It may also be appropriate for
you to seek advice from independent advisers at the Company’s expense. The Company will reimburse the full cost of any expenditure incurred. 
  

 3 

 DATA PROTECTION 
 By signing this agreement you consent to the Company holding and processing information about you which it may acquire during the course of this agreement, providing such use is in accordance with the
Data Protection Act 1998. 
 THIRD PARTY RIGHTS 
 The Contracts (Rights of Third Parties) Act 1999 shall not apply to this agreement. No person other than the parties to this agreement shall have any rights under it and it will not be enforceable by any
person other than the parties to it. 
 ENTIRE AGREEMENT 
 This agreement will constitute the entire and only agreement relating to your appointment between you and the Company. 
 Any previous agreement or arrangement between you and the Company or any Group company shall be deemed to have been terminated by mutual consent as from the commencement of your appointment. 

Please sign and return the enclosed copy of this letter to Susan Henderson, our Company Secretary to confirm your agreement to your appointment on the
above terms. She will be in touch with you shortly to request further information to enable us to fulfil our statutory obligations. 
 A warm
welcome to the Smith & Nephew Board and I look forward to working with you in the future. 
 Yours sincerely 
  

			
	By:	 	 /s/ John Buchanan

	Name:	 	Mr John Buchanan
	Title:	 	Chairman

 I, Ian Barlow, agree to the above terms of
appointment as a non-executive director of Smith & Nephew plc. 
 Dated: 6 March 2010 
  

			
	By:	 	 /s/ Ian Barlow

	Name:	 	Mr Ian Barlow

  

 4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00171-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00171-of-00352.parquet"}]]